Maya Dadiani

Sheba Medical Center — Israel

Medicine · Health Sciences

16h-index3.7kcitations81works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(23), Cancer, Stress, Anesthesia, and Immune Response(21), Cancer Genomics and Diagnostics(13), Breast Cancer Treatment Studies(11), Nanoparticle-Based Drug Delivery(8)

Publications81 total

Abstract PD2-07: Multi-omics characteristics of ER+/HER2- breast cancer switching to metastatic non-luminal subtype: findings from the AURORA study (BIG14-01)
Clinical Cancer Research·2026
Deep phenotyping of health–disease continuum in the Human Phenotype Project
Nature Medicine·2025· 20 cited
Supplementary Figure 5 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Figure 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Table 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Video 1 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Video 5 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Table 1 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Figure 4 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Table 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Video 4 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Figure 6 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Video 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Data from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025· 1 citedOpen Access
Supplementary Table 4 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Figure 8 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Figure 9 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Video 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Figure 7 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Figure 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
page 1 of 5Next →

Frequent Co-authors

Einav Nili Gal‐Yam(32), Iris Barshack(18), Dana Morzaev‐Sulzbach(17), Bella Kaufman(15), Oshrat Levi-Galibov(14), Reinat Nevo(14), Yaniv Stein(14), Ruth Scherz‐Shouval(14), Nora Balint‐Lahat(13), Coral Halperin(13), Shimrit Mayer(13), Ofra Golani(12), Aviad Ben‐Shmuel(11), Yael Gruper(11), Hallel Rosenberg-Fogler(11), Giulia Carradori(11), Gal Yagel(11), Hadassa Degani(10), Debra Barki(10), Mariia Naumova(10)